UnitedHealth Group (NYSE:UNH) Updates FY 2024 Earnings Guidance

UnitedHealth Group (NYSE:UNH) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 27.500-27.750 for the period, compared to the consensus earnings per share estimate of 27.700. The company issued revenue guidance of -.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on UNH. StockNews.com lowered UnitedHealth Group from a buy rating to a hold rating in a research report on Wednesday, September 25th. Royal Bank of Canada upped their price objective on UnitedHealth Group from $555.00 to $615.00 and gave the stock an outperform rating in a report on Wednesday, July 17th. Robert W. Baird upped their price target on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an outperform rating in a research note on Wednesday, July 17th. Barclays increased their price target on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an overweight rating in a report on Wednesday, July 17th. Finally, Argus upped their price objective on UnitedHealth Group from $570.00 to $600.00 and gave the company a buy rating in a research report on Wednesday, July 17th. Two analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of Buy and a consensus target price of $617.37.

UnitedHealth Group Stock Up 1.6 %

NYSE:UNH opened at $607.55 on Tuesday. UnitedHealth Group has a fifty-two week low of $436.38 and a fifty-two week high of $608.63. The company’s 50-day simple moving average is $584.39 and its 200-day simple moving average is $532.15. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. The stock has a market capitalization of $561.02 billion, a P/E ratio of 40.29, a P/E/G ratio of 1.66 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. During the same period in the prior year, the firm posted $6.14 earnings per share. The business’s quarterly revenue was up 6.4% on a year-over-year basis. On average, equities analysts anticipate that UnitedHealth Group will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.38%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is presently 55.70%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.